Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Zoeller JJ"'
Autor:
Bix G, Castello R, Burrows M, Zoeller JJ, Weech M, Lozzo RA, Cardi C, Thakur ML, Barker CA, Camphausen K, Lozzo RV, Bix, Gregory, Castello, Remedios, Burrows, Michelle, Zoeller, Jason J, Weech, Michelle, Iozzo, Rex A, Cardi, Christopher, Thakur, Mathew L, Barker, Christopher A
Publikováno v:
JNCI: Journal of the National Cancer Institute; 11/15/2006, Vol. 98 Issue 22, p1634-1646, 13p
Autor:
Li CM; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. carman_li@hms.harvard.edu., Cordes A; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Oliphant MUJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Quinn SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Thomas M; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Selfors LM; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Silvestri F; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Girnius N; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Rinaldi G; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Zoeller JJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Shapiro H; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Tsiobikas C; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Gupta KP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Pathania S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, USA., Regev A; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Muthuswamy SK; Cancer Research Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. joan_brugge@hms.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. joan_brugge@hms.harvard.edu.
Publikováno v:
Nature genetics [Nat Genet] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.
Autor:
Li CM; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. carman_li@hms.harvard.edu., Cordes A; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Oliphant MUJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Quinn SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Thomas M; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Selfors LM; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Silvestri F; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Girnius N; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Rinaldi G; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Zoeller JJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Shapiro H; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Tsiobikas C; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Gupta KP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Pathania S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, USA., Regev A; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Muthuswamy SK; Cancer Research Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. joan_brugge@hms.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. joan_brugge@hms.harvard.edu.
Publikováno v:
Nature genetics [Nat Genet] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.
Autor:
Schade AE; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Perurena N; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Yang Y; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Rodriguez CL; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Krishnan A; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Gardner A; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Loi P; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Xu Y; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Nguyen VTM; Division of Cancer Biology, Institute of Cancer Research, London, UK., Mastellone GM; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Pilla NF; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Watanabe M; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Ota K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Davis RA; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Mattioli K; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Xiang D; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Zoeller JJ; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Lin JR; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Morganti S; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Garrido-Castro AC; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tolaney SM; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li Z; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sorger PK; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA., Helin K; Division of Cancer Biology, Institute of Cancer Research, London, UK., Santagata S; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA., Knott SRV; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Cichowski K; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. kcichowski@rics.bwh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. kcichowski@rics.bwh.harvard.edu.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA. kcichowski@rics.bwh.harvard.edu.
Publikováno v:
Nature [Nature] 2024 Nov; Vol. 635 (8039), pp. 755-763. Date of Electronic Publication: 2024 Oct 09.
Autor:
Hecht F; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620.; These authors contributed equally., Zocchi M; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620.; These authors contributed equally., Tuttle ET; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Ward NP; Department of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA, 33612., Smith B; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Kang YP; Department of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA, 33612., Cazarin J; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Soares ZG; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Ozgurses ME; Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago, IL, USA, 60612., Zhao H; Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago, IL, USA, 60612., Sheehan C; Ben May Department of Cancer Research, University of Chicago, Chicago, IL, USA, 60637., Alimohammadi F; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Munger LD; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Trivedi D; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Asantewaa G; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA, 14642., Blick-Nitko SK; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620., Zoeller JJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA, 02115., Chen Y; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA, 06510., Vasiliou V; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA, 06510., Turner BM; Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA, 14620., Muir A; Ben May Department of Cancer Research, University of Chicago, Chicago, IL, USA, 60637., Coloff JL; Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago, IL, USA, 60612., Munger J; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA, 14642., DeNicola GM; Department of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA, 33612., Harris IS; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA, 14620.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA, 14620.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 13. Date of Electronic Publication: 2024 Oct 13.
Autor:
Wang Q; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Bergholz JS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Ding L; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Lin Z; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China., Kabraji SK; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Hughes ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., He X; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Xie S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Jiang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Wang W; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Zoeller JJ; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA., Kim HJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Roberts TM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dillon DA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zhao JJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. jean_zhao@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. jean_zhao@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. jean_zhao@dfci.harvard.edu.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA. jean_zhao@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2022 May 31; Vol. 13 (1), pp. 3022. Date of Electronic Publication: 2022 May 31.
Autor:
Daniels VW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ludwig Center at Harvard, Boston, MA 02215, USA., Zoeller JJ; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA., van Gastel N; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., McQueeney KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Potter DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Fell GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ferreira VG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP 13568-250, Brazil.; Instituto Nacional de Ciência e Tecnologia de Bioanalítica, INCTBio, Campinas, SP 13083-970, Brazil., Yilma B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gupta R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Spetz J; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA 02215, USA., Bhola PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Endress JE; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA., Harris IS; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.; Department of Biomedical Genetics and Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, USA., Carrilho E; Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP 13568-250, Brazil.; Instituto Nacional de Ciência e Tecnologia de Bioanalítica, INCTBio, Campinas, SP 13083-970, Brazil., Sarosiek KA; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA 02215, USA., Scadden DT; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Brugge JS; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. anthony_letai@dfci.harvard.edu.; Ludwig Center at Harvard, Boston, MA 02215, USA.
Publikováno v:
Science signaling [Sci Signal] 2021 Jun 08; Vol. 14 (686). Date of Electronic Publication: 2021 Jun 08.
Autor:
Zoeller JJ; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, United States of America., Press MF; Pathology, University of Southern California, Los Angeles, California, United States of America., Selfors LM; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, United States of America., Dering J; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine University of California, Jonsson Comprehensive Cancer Center, Los Angeles, California, United States of America., Slamon DJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine University of California, Jonsson Comprehensive Cancer Center, Los Angeles, California, United States of America., Hurvitz SA; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine University of California, Jonsson Comprehensive Cancer Center, Los Angeles, California, United States of America., Brugge JS; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2021 May 05; Vol. 16 (5), pp. e0251163. Date of Electronic Publication: 2021 May 05 (Print Publication: 2021).
Autor:
Zoeller JJ; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Avenue, Boston, MA, 02115, USA., Vagodny A; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Avenue, Boston, MA, 02115, USA., Daniels VW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Taneja K; Department of Pathology, Brigham & Women's Hospital, Boston, MA, USA., Tan BY; Department of Pathology, Brigham & Women's Hospital, Boston, MA, USA., DeRose YS; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Fujita M; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Welm AL; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leverson JD; Oncology Development, AbbVie, North Chicago, IL, USA., Blot V; Oncology Development, AbbVie, North Chicago, IL, USA., Bronson RT; Department of Pathology, Harvard Medical School, Boston, MA, USA., Dillon DA; Department of Pathology, Brigham & Women's Hospital, Boston, MA, USA., Brugge JS; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Avenue, Boston, MA, 02115, USA. joan_brugge@hms.harvard.edu.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2020 Nov 30; Vol. 22 (1), pp. 132. Date of Electronic Publication: 2020 Nov 30.
Autor:
Hurvitz SA; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. SHurvitz@mednet.ucla.edu., Caswell-Jin JL; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., McNamara KL; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, California, USA., Zoeller JJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Bean GR; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Dichmann R; Central Coast Medical Oncology, Santa Maria, CA, USA., Perez A; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA., Patel R; Comprehensive Blood & Cancer Center, Bakersfield, CA, USA., Zehngebot L; Florida Cancer Specialists & Research Institute, Orlando, FL, USA., Allen H; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Bosserman L; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., DiCarlo B; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Kennedy A; FCPP Hematology/Oncology, San Luis Obispo, CA, USA., Giuliano A; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Calfa C; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA., Molthrop D; Florida Cancer Specialists & Research Institute, Orlando, FL, USA., Mani A; Genentech, South San Francisco, CA, USA., Chen HW; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Dering J; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Adams B; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Kotler E; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, California, USA., Press MF; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Curtis C; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. cncurtis@stanford.edu.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cncurtis@stanford.edu.; Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. cncurtis@stanford.edu., Slamon DJ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Publikováno v:
Nature communications [Nat Commun] 2020 Nov 17; Vol. 11 (1), pp. 5824. Date of Electronic Publication: 2020 Nov 17.